Literature DB >> 19821094

Genetic mutation of vitamin K-dependent gamma-glutamyl carboxylase domain in patients with calcium oxalate urolithiasis.

Jiankun Qiao1, Tao Wang, Jun Yang, Jihong Liu, Xiaoxin Gong, Xiaolin Guo, Shaogang Wang, Zhangqun Ye.   

Abstract

To investigate the exon mutation of vitamin K-dependent gamma-glutamyl carboxylase (GGCX or VKDC) in patients with calcium oxalate urolithasis, renal cortex and peripheral blood samples were obtained from severe hydronephrosis patients (with or without calculi), and renal tumor patients undergoing nephrectomy. GGCX mutations in all 15 exons were examined in 44 patients with calcium oxalate urolithiasis (COU) by polymerase chain reaction (PCR) and denatured high pressure liquid chromatography (DHPLC), and confirmed by sequencing. Mutation was not found in all COU samples compared to the controls. These data demonstrated that functional GGCX mutations in all 15 exons do not occur in most COU patients. It was suggested that there may be no significant association between the low activity and mutation of GGCX in COU.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821094     DOI: 10.1007/s11596-009-0514-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  19 in total

1.  High-throughput SNP detection by using DNA pooling and denaturing high performance liquid chromatography (DHPLC).

Authors:  J K Wolford; D Blunt; C Ballecer; M Prochazka
Journal:  Hum Genet       Date:  2000-11       Impact factor: 4.132

2.  Genomic sequence and transcription start site for the human gamma-glutamyl carboxylase.

Authors:  S M Wu; D W Stafford; L D Frazier; Y Y Fu; K A High; K Chu; B Sanchez-Vega; J Solera
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

3.  Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex.

Authors:  J Oldenburg; B von Brederlow; A Fregin; S Rost; W Wolz; W Eberl; S Eber; E Lenz; R Schwaab; H H Brackmann; W Effenberger; U Harbrecht; L J Schurgers; C Vermeer; C R Müller
Journal:  Thromb Haemost       Date:  2000-12       Impact factor: 5.249

4.  Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity.

Authors:  P K Grover; R L Ryall
Journal:  Eur J Biochem       Date:  1999-07

5.  Enhanced renal vitamin-K-dependent gamma-glutamyl carboxylase activity in experimental rat urolithiasis.

Authors:  N Angayarkanni; R Selvam
Journal:  Eur Urol       Date:  1998       Impact factor: 20.096

6.  Founder mutation Arg485Pro led to recurrent compound heterozygous GGCX genotypes in two German patients with VKCFD type 1.

Authors:  Simone Rost; Christof Geisen; Andreas Fregin; Erhard Seifried; Clemens R Müller; Johannes Oldenburg
Journal:  Blood Coagul Fibrinolysis       Date:  2006-09       Impact factor: 1.276

7.  Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing.

Authors:  Leslie Y Chen; Niclas Eriksson; Rhian Gwilliam; David Bentley; Panos Deloukas; Mia Wadelius
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

8.  Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin.

Authors:  A M Stapleton; R L Ryall
Journal:  Br J Urol       Date:  1995-06

9.  Decreased renal vitamin K-dependent gamma-glutamyl carboxylase activity in calcium oxalate calculi patients.

Authors:  Junhui Chen; Jihong Liu; Yongshang Zhang; Zhangqun Ye; Shaogang Wang
Journal:  Chin Med J (Engl)       Date:  2003-04       Impact factor: 2.628

10.  Cloning of rat vitamin K-dependent gamma-glutamyl carboxylase and developmentally regulated gene expression in postimplantation embryos.

Authors:  E E Romero; L J Velazquez-Estades; R Deo; B Schapiro; D A Roth
Journal:  Exp Cell Res       Date:  1998-09-15       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.